He is doing himself no favours by contesting against Annie Raja in Wayanad

Plog along with this enthusiastic group in Chennai that is intent on mixing jogging and picking up after themselves

Mike Huckabee, the former governor of Arkansas and long-time advocate for Israel, has been chosen to serve as the next U.S. Ambassador to Israel. 

Good Morning America food editor Sara Moulton’s picks for
Best Cookbook of the Year included Knives Cooks Love: Selection. Care. Techniques. Recipes. by Sur La Table with Sarah Jay.

The segment aired 12/23:

http://abcnews.go.com/GMA/HolidayTheme/story?id=6511192&page=1

Noem faced widespread backlash in April when she wrote in a memoir that she shot to death an "untrainable" dog that she "hated" on her family farm

Neymar has time to recover before his next game, however, as he is not registered for the team’s matches in the Saudi Pro League and the next fixture in the AFC competition is on Nov. 25.

The high price for gold has also given a boost to diamond jewellers as customers look for alternatives

"Our work will provide a strong foundation for the new transition team leadership as they move into the post-election phase, which naturally is incorporating the campaign team in New York who drove President-elect Trump to an incredible victory last Tuesday," Mr. Rogers said.

The new members are Ram Singh, Saugata Bhattacharya and Nagesh Kumar. They have been appointed for a period of four years.

Kasparov, who held the record for being the youngest world championship contender before Gukesh broke the record as a 17-year-old by winning this year's Candidates tournament, supported Carlsen's decision to forfeit his title.

President-elect Donald Trump will nominate former Arkansas Gov. Mike Huckabee as ambassador to Israel

John Ratcliffe served as director of national intelligence at the end of Donald Trump’s first term

BJP president Sukanta Majumdar targets police whereas Trinamool leader Firhad Hakim apologises  for comment on woman BJP leader

By picking Rubio and Waltz as his top diplomat and NSA guarantees a continuation of bi-partisan support and further strengthening of India-US relationship under the second Trump administration.

Born risk-taker learns from mistakes and pays attention to detail in the horse trade

In this week's Match of Their Day, former Manchester United and Everton player Phil Neville selects his three favourite Premier League games.

In this week's Match of Their Day, former Manchester United and Everton player Phil Neville selects his three favourite Premier League games.

Among pharma stocks, the top stock picks of CLSA are Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare, recommending a 'buy' rating on them

Our weekly roundup of books that should be on your radar.

AFL greats Dermott Brereton and David King have debated the merits of a severe penalty for the Adelaide Crows, following a “training malfunction” on Thursday.

TDG vs HST Dream11 Team - Check My Dream11 Team, Best players list of today's match, Taiwan Dragons vs Hsinchu Titans Dream11 Team Player List, TDG Dream11 Team Player List, HST Dream11 Team Player List, Dream11 Guru Tips, Online Cricket Tips, Taiwan Dragons vs Hsinchu Titans Head to Head.

Apart from releasing the teaser of 'Tere Bina', Salman Khan wished his fans 'a very happy Mothers' Day'

Taiwan Dragons vs Hsinchu Titans, Dream11 Prediction: Best picks for TDG vs...

Taiwan Dragons vs Taiwan Daredevils, Dream11 Prediction: Best picks fo...

Hsinchu Titans vs Taiwan Daredevils, Dream11 Prediction: Best picks for HST...

In a surprising turn of events on Saturday, the Congress announced two candidates for the May 21 Legislative Council polls, indicating that it is in n

TDG vs TDR Dream11 Team - Check My Dream11 Team, Best players list of today's match, Taiwan Dragons vs Taiwan Daredevils Dream11 Team Player List, TDG Dream11 Team Player List, TDR Dream11 Team Player List, Dream11 Guru Tips, Online Cricket Tips, Taiwan Dragons vs Taiwan Daredevils Head to Head.

HST vs TDR Dream11 Team - Check My Dream11 Team, Best players list of today's match, Hsinchu Titans vs Taiwan Daredevils Dream11 Team Player List, TDG Dream11 Team Player List, HST Dream11 Team Player List, Dream11 Guru Tips, Online Cricket Tips, Hsinchu Titans vs Taiwan Daredevils Head to Head.

Source: Streetwise Reports   04/28/2020

News Flash: On May 7, CloudMD announced that it is partnering with IDYA4 Corp. for it to resell the health technology firm's Livecare technology in the U.S.. Read more here.

News Flash: On May 4, CloudMD announced that it is partnering with Save-On-Foods grocery stores and Pure Integrative Pharmacy to pilot on demand, integrated virtual patient care through telemedicine kiosks placed in pharmacies' existing consult rooms. Read more here.

As people are avoiding going to doctor's offices and hospitals during the coronavirus pandemic, telemedicine has taken off. Two investment professionals, Bruce Campbell and Keith Schaefer, have called CloudMD Software & Services Inc. (DOC:CSE; DOCRF:OTCQB; 6PH:FSE), a small-cap Canadian telemedicine firm, a top pick.

Bruce Campbell, founder and portfolio manager of Stonecastle Investment Management, spoke about CloudMD on April 27 on BNN:

"The first top pick is CloudMD Software, a technological medical play. We've tried to look at opportunities that are really going to be able to take advantage of Covid and this is one of the ones that we think is; what they do is telemedicine.

"The jumping off point for TeleHealth is here and I think CloudMD is the best pure-play TeleHealth stock right now." - Keith Schaefer

If you look back at a year ago, where everyone had to go to the doctor, and now all of the different provinces have opened up billing codes, so that now we don't have to go into a doctor's office. We can do a virtual doctor's visit and the doctor gets paid just like they do with an in-house appointment. Obviously with everything that has happened with this crisis, people really don't want to go into a doctor's office and they need a prescription renewal or something like that.

If you look at CloudMD's peers in the U.S., there is a company called Teladoc, which is a big U.S. company that does the same thing. Obviously, the size of the market is different, but the multiple it trades at is multiple times higher than where CloudMD is.

CloudMD is just starting to gain adoption. They started off here in BC, they have moved to Ontario, and they are going to be rolling out really across the country, so tons of opportunity for a company like this. They will probably change the way that we view our doctor and our healthcare visits going forward."

Keith Schaefer, editor and publisher of Oil & Gas Investments Bulletin, is also following CloudMD, and wrote:

"An entirely new—and highly profitable—industry is being borne out in 2020—TeleHealth. CloudMD Software & Services Inc. (DOC:CSE; DOCRF:OTCQB; 6PH:FSE) is my favorite way to play TeleHealth. It's growing quickly with over 100,000 patients registered on its app and over 3000 doctors in 8 provinces in its Electronic Medical Records—EMR—system. It has MULTIPLE revenue streams and it just moved into Canada's largest market—Ontario—setting up an even faster growth rate.

The recent spread of coronavirus is only accelerating this. Covid-19 has forever changed how we all will think about visiting a hospital or seeing our doctor. We really don't want to do that at all, if possible. It will have a very positive and long lasting impact on TeleHealth.

TeleHealth companies in Canada are getting paid more money for services than bricks-and-mortar clinics, and have a fraction of the costs. Doctors want more of it, patients want more of it, government wants more of it—and the Market REALLY wants more of it. Everybody wins here; there is no downside.

The rapid scale-up and profitability is key for investors.

CloudMD is established, growing quickly and trading at a fraction of its peers. The average multiple of competitors in the sector trade at 5-7x revenue, and CloudMD is trading way below that at 2.5x per revenue. But realize that the Canadian use of telemedicine is still just a fraction of where it is in the U.S—so the quick, early upside is even bigger.

The market desperately wants to own TeleHealth right now. I see CloudMD as the best way to do that in the junior sector (where the leverage is!).

For this stock to have a major run all that needs to happen is for institutional investors to wake-up to the fact that the company exists. That's happening now with the company entering the province of Ontario—which has 14.5 million people—over one-third of Canada's population.

CloudMD is a fully integrated health care company—kind of like a hospital-in-the-sky. They do have five bricks-and-mortar clinics, but they also own their own EMR—Electronic Medical Records—system that operates in eight provinces and is used by over 3,000 doctors and is supported by an in-house 25 person development team. They have their own CloudMD app—which has over 100,000 registered patients already.

The EMR gives CloudMD a recurring monthly revenue stream, which The Street loves. The app gives them high-margin fees from doctors, specialists and groups like massage therapists & counselors. These people are revenue, not costs. As I said, full hospital-in-the-sky. Multiple revenue sources with lower costs.

To schedule a virtual doctor's appointment all that a patient has to do is download the free CloudMD app and then arrange an appointment with one of the doctors. There is zero charge for the patient and they can see a doctor very quickly.

CloudMD can scale up the number of patients VERY quickly—and they are. Every aspect of healthcare that's very fractured and disjointed will now be in the one CloudMD ecosystem.
Everyone wins with this system. Patients, doctors, the medical system, society, even investors. Everyone.

Doctors who have signed up with CloudMD work remotely from home or wherever they are (like their winter home down south). The rapid scale-up potential excites me. CloudMD can add in unlimited number of doctors and patients—so it has a virtually unlimited ability to scale quickly with little incremental cost.

Profit margins are wide and there is no cap on the number of customers that can be handled.

After a patient has an appointment, CloudMD bills the government directly just like every bricks-and-mortar clinic in Canada does. CloudMD records 100% of the revenue and gets to keep 30% of the billing for every patient that is seen through telemedicine, which is actually 10% more than what a bricks-and-mortar clinic receives. That is because the governments are trying to push TeleHealth. The doctor gets the other 70% and doesn't have to deal with any headaches of commuting or running a business.

Without the overhead of a bricks-and-mortar clinic, AND more revenue, CloudMD will be much more profitable than traditional healthcare stocks. Faster scale, more cash flow. And they just entered Canada's largest market. This is the right stock in the right market at the right time. That's the great thing about this business model. It's very scalable, very easy, and it grows very quickly.

CloudMD has been growing its recurring SAAS (Software-as-a-Service) revenue by 30% YoY with its EMR system. But this year the company is expecting that doctor growth to be much much higher—with a new full time sales team and the coronavirus pandemic. SaaS revenue is highly lucrative!

The jumping off point for TeleHealth is here and I think CloudMD is the best pure-play TeleHealth stock right now."

Read Keith Schaefer's entire article here.

Watch Bruce Campbell of StoneCastle Investments share his top picks: CloudMD, Lightspeed and Viemed.

Disclosure:
1) Keith Schaefer: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: CloudMD. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: CloudMD. My company has a financial relationship with the following companies mentioned in this article: None. Additional disclosures are listed below.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with CloudMD. Please click here for more information. An affiliate of Streetwise Reports is conducting a digital media marketing campaign for this article on behalf of CloudMD. Please click here for more information.
3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of CloudMD, a company mentioned in this article.

Additional Disclosures